ERIC
European Research Initiative on CLL
Workpackage 7 (WP7) of the European LeukemiaNet (ELN)
The ERIC is an European organization devoted to improve the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.
There are many more open questions and new drugs available in the treatment of CLL than study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is a key element.
The ERIC is currently funded by the European LeukemiaNet (ELN 
) and acts within the European Hematology
Association (EHA ). The ERIC is OPEN to every physician or
scientist working/interested in the field of chronic lymphocytic
leukemia or related disorders.